Pharma firm’s shares make remarkable market debut with 35% rise, mcap reaches Rs…

Corona Remedies IPO: Shares of pharmaceutical firm Corona Remedies Ltd closed at a premium of over 35 per cent against the issue price of Rs 1,062 per share on Monday. The stock started trading at Rs 1,452 on the BSE, up 36.72 percent from the issue price. It rose 41.14 percent to Rs 1,499 during the day and then settled at Rs 1,437.20, up 35.32 percent. On the NSE, the shares were listed at Rs 1,470, a premium of 38.41 per cent. Shares of the firm ended at Rs 1,438.40, up 35.44 per cent, PTI reported.

Corona Treatments Market Value

The market capitalization of Corona Remedies stood at 8,789.93 billion rupees. In terms of volume, 16.33 lakh shares of the firm were traded on BSE and 128.89 lakh shares were traded on NSE during the day.

Corona Solutions IPO

Corona Solutions’ Initial Public Offering (IPO) was subscribed 137.04 times last week. The price of the Rs 655.37 billion IPO was Rs 1,008-1,062 per share. Headquartered in Ahmedabad, Corona Remedies is a pharmaceutical formulation company engaged in developing, manufacturing and marketing products in women’s health, cardio-diabetes, pain management, urology and other therapeutic areas.